Imperial College London

ProfessorAndrewBush

Faculty of MedicineNational Heart & Lung Institute

Professor of Paediatric Respirology
 
 
 
//

Contact

 

+44 (0)20 7352 8121 ext 2255a.bush

 
 
//

Location

 

Chelsea WingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Bédard:2020:10.1111/all.14204,
author = {Bédard, A and Antó, JM and Fonseca, JA and Arnavielhe, S and Bachert, C and Bedbrook, A and Bindslev-Jensen, C and Bosnic-Anticevich, S and Cardona, V and Cruz, AA and Fokkens, WJ and Garcia-Aymerich, J and Hellings, PW and Ivancevich, JC and Klimek, L and Kuna, P and Kvedariene, V and Larenas-Linnemann, D and Melén, E and Monti, R and Mösges, R and Mullol, J and Papadopoulos, NG and Pham-Thi, N and Samolinski, B and Tomazic, PV and Toppila-Salmi, S and Ventura, MT and Yorgancioglu, A and Bousquet, J and Pfaar, O and Basagaña, X and MASK, study group},
doi = {10.1111/all.14204},
journal = {Allergy},
pages = {1672--1688},
title = {Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App},
url = {http://dx.doi.org/10.1111/all.14204},
volume = {75},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BACKGROUND: In allergic rhinitis, a relevant outcome providing information on the effectiveness of interventions is needed. In MASK-air (Mobile Airways Sentinel Network), a visual analogue scale (VAS) for work is used as a relevant outcome. This study aimed to assess the performance of the work VAS work by comparing VAS work with other VAS measurements and symptom-medication scores obtained concurrently. METHODS: All consecutive MASK-air users in 23 countries from 1 June 2016 to 31 October 2018 were included (14 189 users; 205 904 days). Geolocalized users self-assessed daily symptom control using the touchscreen functionality on their smart phone to click on VAS scores (ranging from 0 to 100) for overall symptoms (global), nose, eyes, asthma and work. Two symptom-medication scores were used: the modified EAACI CSMS score and the MASK control score for rhinitis. To assess data quality, the intra-individual response variability (IRV) index was calculated. RESULTS: A strong correlation was observed between VAS work and other VAS. The highest levels for correlation with VAS work and variance explained in VAS work were found with VAS global, followed by VAS nose, eye and asthma. In comparison with VAS global, the mCSMS and MASK control score showed a lower correlation with VAS work. Results are unlikely to be explained by a low quality of data arising from repeated VAS measures. CONCLUSIONS: VAS work correlates with other outcomes (VAS global, nose, eye and asthma) but less well with a symptom-medication score. VAS work should be considered as a potentially useful AR outcome in intervention studies.
AU - Bédard,A
AU - Antó,JM
AU - Fonseca,JA
AU - Arnavielhe,S
AU - Bachert,C
AU - Bedbrook,A
AU - Bindslev-Jensen,C
AU - Bosnic-Anticevich,S
AU - Cardona,V
AU - Cruz,AA
AU - Fokkens,WJ
AU - Garcia-Aymerich,J
AU - Hellings,PW
AU - Ivancevich,JC
AU - Klimek,L
AU - Kuna,P
AU - Kvedariene,V
AU - Larenas-Linnemann,D
AU - Melén,E
AU - Monti,R
AU - Mösges,R
AU - Mullol,J
AU - Papadopoulos,NG
AU - Pham-Thi,N
AU - Samolinski,B
AU - Tomazic,PV
AU - Toppila-Salmi,S
AU - Ventura,MT
AU - Yorgancioglu,A
AU - Bousquet,J
AU - Pfaar,O
AU - Basagaña,X
AU - MASK,study group
DO - 10.1111/all.14204
EP - 1688
PY - 2020///
SN - 0105-4538
SP - 1672
TI - Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App
T2 - Allergy
UR - http://dx.doi.org/10.1111/all.14204
UR - https://www.ncbi.nlm.nih.gov/pubmed/31995656
UR - http://hdl.handle.net/10044/1/81258
VL - 75
ER -